Paul J. Kim advises clients on mergers and acquisitions (M&A), general corporate matters, private equity, venture capital, securities, restructurings and multi-jurisdictional disputes. Paul has more than 20 years of experience representing a diverse range of clients operating in numerous industries and in many countries. His clients include industrial and manufacturing companies, commercial and investment banks and other financial institutions, and private equity funds and investment managers. Paul has particularly broad experience representing Asian, European and US clients in complex multi-jurisdictional transactions, restructurings and other matters, and has been recognized by The Legal 500 United States, The Legal 500 Asia Pacific and Chambers Asia Pacific.
Paul’s banking, capital markets and trading experience includes working on close to 40 capital market transactions, including US and global depositary receipt (ADR/GDR) offerings and programs, Eurobond offerings, initial public offerings (IPOs), International Swaps and Derivatives Association, Inc. (ISDA), transactions and other capital market transactions, primarily representing investment and commercial banks from the United States as well as from Europe, Latin America and the Middle East.
Paul is admitted as a Foreign Legal Consultant for US Law (New York Lawyer) in the Republic of Korea.
Represented a leading Korean private equity fund sponsor in its KRW 700 billion preferred stock investment in the leading compact farm and construction equipment manufacturer in North America
Represented a leading sportswear and apparel company headquartered in Korea and one of the largest private equity firms in Korea in their US$1.225 billion acquisition of the Acushnet golf business, the owner of the Titleist and Footjoy golf brands, from Fortune Brands, Inc.; the transaction was named “Consumer M&A Deal of the Year” by M&A Advisor magazine and “Korea Deal of the Year” by FinanceAsia magazine
Represented the largest chemicals company in Korea in its acquisition by merger of a California-based, venture-backed developer, manufacturer and distributor of reverse-osmosis membranes used for desalination, for a purchase price of approximately US$200 million
Represented a leading phytomedicines and related health care products group headquartered in Germany in connection with the following:
Representation of its US subsidiary in connection with the acquisition of the business and assets of a leading vitamin, minerals and dietary supplements maker and distributor in the United States
Representation of its global holding company in connection with various transactions and representations relating to its China operations, including representing such company in certain disputes with private Taiwanese and Hong Kong parties, the consummation of two new supply agreements, new license agreements, a noncompetition agreement and terminations of various existing agreements, with an aggregate transaction value of over €300 million
Representation of its global holding company in connection with the renegotiation of its license agreement with its Korean license
Representation of its US subsidiary in connection with the acquisition of a leading maker of dietary and nutritional supplements in the United States, from a private equity fund in a transaction valued at over US$100 million
Represented a leading US growth capital fund manager with more than US$750 million in committed growth capital assets under management, in connection with the following:
The strategic investment in an e-commerce retailer of young women’s apparel, shoes and accessories
The acquisition and subsequent sale of its affiliate’s investment in the market leader in creating, managing and operating digital retail media programs for highly trafficked retail websites, in a sale valued at over US$140 million
The formation of a new portfolio company and the acquisition by such portfolio company of two leading online advertising companies encompassing a number of owned and operated websites, an online advertising network and an affiliate network
Represented the world’s largest diversified technology and electronics company in various proposed acquisitions of US venture-backed companies
Represented the largest pharmaceutical company in Japan in connection with the establishment of a sponsored Level I American Depositary Receipt (ADR) program in the United States and the use of such facility in certain global executive compensation and benefit programs
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.